About: Kenneth R. Chien

An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the Uni

Property Value
dbo:abstract
  • Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the University of Edinburgh. (en)
dbo:academicDiscipline
dbo:almaMater
dbo:award
dbo:institution
dbo:knownFor
dbo:nationality
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 64948319 (xsd:integer)
dbo:wikiPageLength
  • 15918 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1099475529 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
  • Temple University (en)
  • (en)
  • Harvard College (en)
dbp:awards
dbp:fields
  • Biotechnology (en)
  • Stem cell research (en)
  • (en)
  • Cardiovascular research (en)
  • Regenerative cardiovascular medicine (en)
dbp:knownFor
  • (en)
  • Co-founding Moderna (en)
  • Research in the field of cardiovascular biotechnology and regenerative cardiovascular medicine (en)
dbp:name
  • Kenneth Randall Chien (en)
dbp:nationality
dbp:parents
  • Luther Chien (en)
dbp:wikiPageUsesTemplate
dbp:workplaces
  • Harvard University (en)
  • Karolinska Institute (en)
  • Massachusetts General Hospital (en)
  • Temple University (en)
  • (en)
  • UC San Diego-Salk Institute (en)
dcterms:subject
rdf:type
rdfs:comment
  • Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the Uni (en)
rdfs:label
  • Kenneth R. Chien (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • Kenneth Randall Chien (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License